PGP - 2026 Lecture Series
Innovation Award: AI-based melanoma detection
March 14, 2026
Prevention and Care Pathways
Standardized and reliable dermatological analysis using artificial intelligence: the first CE Class IIB-certified medical device in Europe designed to assist in detecting the risk of melanoma in pigmented skin lesions, intended for primary care providers to support clinical decision-making and referrals to specialists.
Speaker(s)




































-(002).png)














